| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/02/1995 | WO1995003330A1 Somatostatin derivatives and their radiolabelled products |
| 02/02/1995 | WO1995003280A1 Hydrazino-type radionuclide chelators having an n3s configuration |
| 02/02/1995 | WO1995003065A1 Scorpion peptide with immunosuppressant activity |
| 02/02/1995 | WO1994029316A3 Texaphyrin metal complex mediated ester hydrolysis |
| 02/02/1995 | CA2167920A1 Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/02/1995 | CA2167167A1 Hydrazino-type radionuclide chelators having an n3s configuration |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636032A1 Method of intraoperatively detecting and locating tumoral tissues |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 01/31/1995 | US5386028 Nuclear magnetic imaging contrast agent; medical diagnosis |
| 01/31/1995 | US5385719 Paramagnetic ion chelated to polymers; x-ray and ultrasonic contrast agents, nuclear medicine imaging, radiotherapy, |
| 01/26/1995 | WO1995002424A1 Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen |
| 01/26/1995 | WO1995002423A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 01/26/1995 | WO1995002418A1 Radionuclide metal chelates for the radiolabeling of ligands, anti-ligands or other proteins |
| 01/26/1995 | DE4426204A1 Diagnostic and its use |
| 01/26/1995 | CA2165537A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 01/26/1995 | CA2165052A1 Radionuclide metal chelates for the radiolabeling of ligands, anti-ligands or other proteins |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |
| 01/25/1995 | CN1097735A Derivative of fatty acid and pharmaceutical composition containg same |
| 01/24/1995 | US5384401 Chemical product usable as a non-radioactive carrier |
| 01/24/1995 | US5384113 Gentisic acid, alcohol or derivatives |
| 01/20/1995 | EP0643696A4 Azavesamicols. |
| 01/18/1995 | EP0395695B1 Tris(isonitrile)copper(i) adducts for preparing radionuclide complexes |
| 01/17/1995 | US5382654 Radiolabelled peptide compounds |
| 01/17/1995 | CA2128175A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 01/12/1995 | WO1995001346A1 Chelating compounds |
| 01/12/1995 | WO1995001188A1 Polyvalent peptide pharmaceutical applications |
| 01/12/1995 | WO1995001184A1 An iodinated neuroprobe for mapping monoamine reuptake sites |
| 01/12/1995 | WO1994019024A3 Technetium-99m labeled peptides for diagnostic imaging |
| 01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
| 01/11/1995 | EP0632729A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 01/10/1995 | US5380848 8-azabicyclo(3.2.1)octanes |
| 01/10/1995 | US5380646 Thrombus detection using radiolabelled disintegrins |
| 01/10/1995 | US5380513 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 01/10/1995 | CA2126819A1 Kit and method for pretargeting |
| 01/05/1995 | WO1995000659A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | WO1995000553A1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 01/05/1995 | CA2165797A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/04/1995 | EP0631507A1 Selective alteration of antibody immunogenicity |
| 01/04/1995 | EP0631503A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 12/28/1994 | EP0630652A2 Contrast media |
| 12/28/1994 | EP0630407A1 Anti-viral fusion peptides |
| 12/28/1994 | EP0630265A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
| 12/28/1994 | EP0630264A1 Ligands for improving metal chelate formation kinetics |
| 12/27/1994 | US5376540 For diagnostic breath tests |
| 12/27/1994 | US5376356 Imaging tissue sites of inflammation |
| 12/27/1994 | US5376355 Method of measurement in biological systems |
| 12/22/1994 | WO1994029338A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
| 12/22/1994 | WO1994029333A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
| 12/22/1994 | WO1994029316A2 Texaphyrin metal complex mediated ester hydrolysis |
| 12/22/1994 | WO1994028942A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
| 12/22/1994 | WO1994028941A1 Liver function breath test using aromatic amino acids |
| 12/22/1994 | WO1994028940A1 Blood pool imaging composition and method of its use |
| 12/22/1994 | WO1994028909A1 Antineoplastic compositions and methods of use |
| 12/22/1994 | WO1994028875A1 Compositions for boron neutron capture therapy and methods thereof |
| 12/22/1994 | DE4345200A1 Pharmaceutical composition for the treatment of immune reactions |
| 12/22/1994 | CA2164854A1 Liver function breath test using aromatic amino acids |
| 12/22/1994 | CA2164518A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | CA2164419A1 Texaphyrin metal complex mediated ester hydrolysis |
| 12/22/1994 | CA2163996A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
| 12/22/1994 | CA2162995A1 Compositions for boron neutron capture therapy and methods thereof |
| 12/21/1994 | EP0629617A1 Heteroatom-bearing ligands and metal complexes thereof |
| 12/21/1994 | EP0629133A1 Protein- and peptide-metal ion pharmaceutical applications |
| 12/21/1994 | EP0485563B1 Polyether-substituted tumor agents |
| 12/20/1994 | US5374416 Diagnostic,therapeutic agent for nuclear magnetic resonance, radiology |
| 12/14/1994 | EP0627941A1 Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor |
| 12/14/1994 | EP0627940A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 12/14/1994 | EP0627939A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 12/14/1994 | EP0627937A1 Sodium iodide ?131 i capsules |
| 12/13/1994 | US5373093 Suitable in preparation of reproter molecules and for magnetic resonance, radiation imaging and and radiation therapy |
| 12/13/1994 | US5372933 Antibody-polypeptide immunocomplex |
| 12/13/1994 | US5372813 Substituted 6-nitroquipazines, methods of preparation, and methods of use |
| 12/08/1994 | WO1994028412A1 Composition and method for in vivo imaging of amyloid deposits |
| 12/08/1994 | WO1994027653A2 The intrapulmonary delivery of aerosolized aqueous formulations |
| 12/08/1994 | WO1994027644A1 Iodinated paramagnetic chelates, and their use as contrast agents |
| 12/08/1994 | WO1994027605A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
| 12/08/1994 | CA2163867A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
| 12/06/1994 | US5371199 Substituted porphyrins, porphyrin-containing polymers, and synthetic methods therefor |
| 12/06/1994 | US5371184 Radiolabelled peptide compounds |
| 11/29/1994 | US5369101 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles |
| 11/29/1994 | CA1333265C Coupling agents for radiolabeling proteins |
| 11/29/1994 | CA1333264C Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi |
| 11/24/1994 | WO1994026755A1 Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals |
| 11/24/1994 | WO1994026754A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 11/24/1994 | WO1994026315A1 Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals |
| 11/24/1994 | WO1994026314A1 Compounds for cancer imaging and therapy |
| 11/24/1994 | WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 11/24/1994 | WO1994026295A1 Metal chelates as spacer compounds in biologically active peptides |
| 11/24/1994 | WO1994026294A1 Ligand precursors for incorporation into peptides |
| 11/24/1994 | WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 11/24/1994 | WO1994026275A1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 11/24/1994 | WO1994026205A1 Vascular implant |
| 11/24/1994 | CA2162174A1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 11/24/1994 | CA2139503A1 Compounds for cancer imaging and therapy |
| 11/23/1994 | EP0625200A1 Biosynthetic binding protein for cancer marker |
| 11/23/1994 | EP0625055A1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 11/23/1994 | EP0625054A1 Stabilized radiopharmaceutical kits |
| 11/23/1994 | EP0464101B1 Improvements relating to the radio-labelling of proteins |